Pharmabiz

Intralink to drive Dyadic Applied BioSolutions’ expansion into Japan and Korea

Intralink to drive Dyadic Applied BioSolutions’ expansion into Japan and Korea: Oxford, UK Saturday, November 8, 2025, 17:00 Hrs [IST] International business development consult ...
Pharmabiz

ClearPoint Neuro to acquire IRRAS Holdings to expand its drug delivery portfolio

ClearPoint Neuro to acquire IRRAS Holdings to expand its drug delivery portfolio: Solana Beach, California Saturday, November 8, 2025, 16:00 Hrs [IST] ClearPoint Neuro Inc, a glob ...
Pharmabiz

iiCON boosts regional R&D spend to over £1billion

The Infection Innovation Consortium: iiCON has marked its fifth year of operations with the launch of a new report highlighting its significant impact over the last 12 months. The consortium, which is ...
Pharmabiz

Lupin Bioresearch Centre receives zero observations from US FDA after successful inspection and assessment

Lupin Bioresearch Centre receives zero observations from US FDA after successful inspection and assessment: Our Bureau, Mumbai Saturday, November 8, 2025, 13:20 Hrs [IST] Global p ...
Pharmabiz

UK MHRA approves Serum Life Sciences’ Siiltibcy as a diagnostic aid for Mycobacterium tuberculosis infection, including disease

UK MHRA approves Serum Life Sciences’ Siiltibcy as a diagnostic aid for Mycobacterium tuberculosis infection, including disease: United Kingdom Saturday, November 8, 2025, 14:00 ...
Pharmabiz

ORIC Pharmaceuticals announces scientific details of discovery and development of enozertinib

ORIC Pharmaceuticals announces scientific details of discovery and development of enozertinib: South San Francisco Saturday, November 8, 2025, 13:00 Hrs [IST] ORIC Pharmaceuticals ...
Pharmabiz

Eli Lilly appoints new executive committee members; expands leadership roles to prepare for next wave of growth

Eli Lilly appoints new executive committee members; expands leadership roles to prepare for next wave of growth: Indianapolis Saturday, November 8, 2025, 11:00 Hrs [IST] Eli Lilly ...
Pharmabiz

Zydus receives US FDA tentative approval for olaparib tablets, 100 mg and 150 mg

Zydus receives US FDA tentative approval for olaparib tablets, 100 mg and 150 mg: Our Bureau, Mumbai Saturday, November 8, 2025, 10:30 Hrs [IST] Zydus Lifesciences Limited has rec ...
Pharmabiz

Alvotech and Advanz Pharma receive UK MHRA marketing approval for Gobivaz

Alvotech and Advanz Pharma receive UK MHRA marketing approval for Gobivaz: Reykjavik, Iceland Saturday, November 8, 2025, 12:00 Hrs [IST] Alvotech, a global biotech company specia ...
Pharmabiz

Harbour BioMed & Evinova China enter strategic AI collaboration to accelerate AI-enabled drug development

Harbour BioMed & Evinova China enter strategic AI collaboration to accelerate AI-enabled drug development: Cambridge, Massachusetts Saturday, November 8, 2025, 10:00 Hrs [IST] Har ...
Pharmabiz

University of Glasgow’s bioengineered bone marrow model successfully used in leukaemia research

University of Glasgow’s bioengineered bone marrow model successfully used in leukaemia research: Our Bureau, Bengaluru Saturday, November 8, 2025, 09:00 Hrs [IST] University of ...
Pharmabiz

Pharmexcil to organise India Pavilion at World Health Expo, Dubai to be held from Feb 9 to 12, 2026

Pharmexcil to organise India Pavilion at World Health Expo, Dubai to be held from Feb 9 to 12, 2026: Shardul Nautiyal, Mumbai Saturday, November 8, 2025, 08:00 Hrs [IST] The Pharm ...